Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04DFX
|
||||
| Former ID |
DNC011261
|
||||
| Drug Name |
Bis(3-bromophenyl)(4-hydroxy)thiosemicarbazone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531200] | ||
| Formula |
C14H11Br2N3OS
|
||||
| Canonical SMILES |
C1=CC(=CC(=C1)Br)C(=C2C=CC(=O)C(=C2)Br)NNC(=S)N
|
||||
| InChI |
1S/C14H11Br2N3OS/c15-10-3-1-2-8(6-10)13(18-19-14(17)21)9-4-5-12(20)11(16)7-9/h1-7,18H,(H3,17,19,21)/b13-9+
|
||||
| InChIKey |
NPYRRUVCJBHCQQ-UKTHLTGXSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | Inhibitor | [531200] | |
| Cathepsin B | Target Info | Inhibitor | [531200] | ||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||